Dexcom Inc Stock Gross Profit

DXCM Stock

USD 134.56 1.58 1.16%

DexCom Inc fundamentals help investors to digest information that contributes to DexCom's financial success or failures. It also enables traders to predict the movement of DexCom Stock. The fundamental analysis module provides a way to measure DexCom's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DexCom stock.

	Last Reported	Projected for Next Year
Gross Profit	2.3 B	2.4 B
Gross Profit Margin	0.63	0.66

As of the 15th of April 2024, Gross Profit is likely to grow to about 2.4 B. Also, Gross Profit Margin is likely to grow to 0.66.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

DexCom Inc Company Gross Profit Analysis

DexCom's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current DexCom Gross Profit

1.88 B

Most of DexCom's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DexCom Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

DexCom Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for DexCom is extremely important. It helps to project a fair market value of DexCom Stock properly, considering its historical fundamentals such as Gross Profit. Since DexCom's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DexCom's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DexCom's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Total Liab	Common Stock	Property Plant Equipment	Short Term Investments	Long Term Debt	Net Receivables	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Good Will	Capital Surpluse	Treasury Stock	Intangible Assets	Long Term Debt Total	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.95	1.0	0.81	0.75	0.99	0.81	0.98	0.98	0.97	0.97	0.4	0.76	1.0	0.81	0.84	0.88	-0.92	0.87	0.85	0.91	0.86	0.96	0.92	0.8
Total Stockholder Equity	0.98		0.89	0.98	0.73	0.8	0.96	0.72	0.94	0.97	0.93	0.92	0.42	0.65	0.99	0.8	0.87	0.92	-0.93	0.81	0.89	0.89	0.81	0.98	0.94	0.7
Net Debt	0.95	0.89		0.93	0.9	0.63	0.97	0.89	0.96	0.96	0.91	0.97	0.37	0.86	0.94	0.68	0.67	0.74	-0.83	0.89	0.7	0.79	0.81	0.88	0.81	0.89
Total Current Assets	1.0	0.98	0.93		0.76	0.73	0.99	0.77	0.95	0.98	0.98	0.96	0.36	0.73	0.99	0.83	0.86	0.9	-0.92	0.83	0.89	0.93	0.87	0.96	0.94	0.75
Retained Earnings	0.81	0.73	0.9	0.76		0.51	0.84	0.88	0.88	0.79	0.75	0.88	0.35	0.94	0.8	0.42	0.42	0.52	-0.69	0.87	0.44	0.54	0.65	0.74	0.62	0.92
Accounts Payable	0.75	0.8	0.63	0.73	0.51		0.7	0.58	0.75	0.71	0.58	0.67	0.81	0.41	0.75	0.61	0.8	0.77	-0.83	0.78	0.7	0.68	0.54	0.8	0.63	0.55
Total Liab	0.99	0.96	0.97	0.99	0.84	0.7		0.85	0.98	0.97	0.97	0.99	0.37	0.82	0.98	0.8	0.8	0.85	-0.91	0.89	0.82	0.9	0.88	0.94	0.89	0.84
Common Stock	0.81	0.72	0.89	0.77	0.88	0.58	0.85		0.89	0.76	0.75	0.91	0.47	0.91	0.78	0.57	0.54	0.56	-0.71	0.95	0.43	0.63	0.71	0.71	0.55	0.99
Property Plant Equipment	0.98	0.94	0.96	0.95	0.88	0.75	0.98	0.89		0.94	0.92	0.99	0.44	0.84	0.97	0.74	0.77	0.81	-0.9	0.93	0.74	0.82	0.82	0.92	0.83	0.88
Short Term Investments	0.98	0.97	0.96	0.98	0.79	0.71	0.97	0.76	0.94		0.95	0.94	0.37	0.71	0.98	0.76	0.8	0.87	-0.89	0.81	0.86	0.88	0.83	0.96	0.93	0.74
Long Term Debt	0.97	0.93	0.91	0.98	0.75	0.58	0.97	0.75	0.92	0.95		0.95	0.17	0.75	0.96	0.83	0.8	0.85	-0.87	0.76	0.86	0.93	0.9	0.91	0.93	0.73
Net Receivables	0.97	0.92	0.97	0.96	0.88	0.67	0.99	0.91	0.99	0.94	0.95		0.36	0.87	0.96	0.77	0.75	0.79	-0.87	0.91	0.73	0.85	0.86	0.9	0.83	0.9
Short Term Debt	0.4	0.42	0.37	0.36	0.35	0.81	0.37	0.47	0.44	0.37	0.17	0.36		0.27	0.38	0.23	0.41	0.38	-0.48	0.66	0.29	0.3	0.19	0.46	0.19	0.47
Current Deferred Revenue	0.76	0.65	0.86	0.73	0.94	0.41	0.82	0.91	0.84	0.71	0.75	0.87	0.27		0.74	0.52	0.42	0.47	-0.63	0.86	0.38	0.59	0.71	0.64	0.53	0.95
Net Tangible Assets	1.0	0.99	0.94	0.99	0.8	0.75	0.98	0.78	0.97	0.98	0.96	0.96	0.38	0.74		0.79	0.83	0.89	-0.92	0.84	0.86	0.88	0.84	0.97	0.93	0.77
Total Permanent Equity	0.81	0.8	0.68	0.83	0.42	0.61	0.8	0.57	0.74	0.76	0.83	0.77	0.23	0.52	0.79		0.9	0.84	-0.75	0.62	0.82	0.91	0.83	0.75	0.76	0.52
Good Will	0.84	0.87	0.67	0.86	0.42	0.8	0.8	0.54	0.77	0.8	0.8	0.75	0.41	0.42	0.83	0.9		0.97	-0.85	0.65	0.92	0.9	0.84	0.88	0.85	0.48
Capital Surpluse	0.88	0.92	0.74	0.9	0.52	0.77	0.85	0.56	0.81	0.87	0.85	0.79	0.38	0.47	0.89	0.84	0.97		-0.88	0.67	0.96	0.9	0.88	0.94	0.93	0.51
Treasury Stock	-0.92	-0.93	-0.83	-0.92	-0.69	-0.83	-0.91	-0.71	-0.9	-0.89	-0.87	-0.87	-0.48	-0.63	-0.92	-0.75	-0.85	-0.88		-0.81	-0.85	-0.87	-0.79	-0.93	-0.87	-0.68
Intangible Assets	0.87	0.81	0.89	0.83	0.87	0.78	0.89	0.95	0.93	0.81	0.76	0.91	0.66	0.86	0.84	0.62	0.65	0.67	-0.81		0.56	0.7	0.72	0.81	0.62	0.95
Long Term Debt Total	0.85	0.89	0.7	0.89	0.44	0.7	0.82	0.43	0.74	0.86	0.86	0.73	0.29	0.38	0.86	0.82	0.92	0.96	-0.85	0.56		0.92	0.82	0.91	0.95	0.4
Short Long Term Debt	0.91	0.89	0.79	0.93	0.54	0.68	0.9	0.63	0.82	0.88	0.93	0.85	0.3	0.59	0.88	0.91	0.9	0.9	-0.87	0.7	0.92		0.89	0.87	0.89	0.59
Long Term Investments	0.86	0.81	0.81	0.87	0.65	0.54	0.88	0.71	0.82	0.83	0.9	0.86	0.19	0.71	0.84	0.83	0.84	0.88	-0.79	0.72	0.82	0.89		0.85	0.84	0.69
Net Invested Capital	0.96	0.98	0.88	0.96	0.74	0.8	0.94	0.71	0.92	0.96	0.91	0.9	0.46	0.64	0.97	0.75	0.88	0.94	-0.93	0.81	0.91	0.87	0.85		0.95	0.69
Net Working Capital	0.92	0.94	0.81	0.94	0.62	0.63	0.89	0.55	0.83	0.93	0.93	0.83	0.19	0.53	0.93	0.76	0.85	0.93	-0.87	0.62	0.95	0.89	0.84	0.95		0.52
Capital Stock	0.8	0.7	0.89	0.75	0.92	0.55	0.84	0.99	0.88	0.74	0.73	0.9	0.47	0.95	0.77	0.52	0.48	0.51	-0.68	0.95	0.4	0.59	0.69	0.69	0.52

Click cells to compare fundamentals

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict DexCom

Gross Profit Over Time

According to the company disclosure, DexCom Inc reported 1.88 B of gross profit. This is 16.05% lower than that of the Health Care Equipment & Supplies sector and 16.79% higher than that of the Health Care industry. The gross profit for all United States stocks is 93.12% higher than that of the company.

DexCom Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DexCom's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics of similar companies.

DexCom is currently under evaluation in gross profit category among related companies.

DexCom ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, DexCom's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to DexCom's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

DexCom Fundamentals

	Return On Equity	0.26
	Return On Asset	0.0641
	Profit Margin	0.15 %
	Operating Margin	0.21 %
	Current Valuation	52.37 B
	Shares Outstanding	385.52 M
	Shares Owned By Insiders	0.41 %
	Shares Owned By Institutions	99.59 %
	Number Of Shares Shorted	14.57 M
	Price To Earning	245.31 X
	Price To Book	25.38 X
	Price To Sales	14.49 X
	Revenue	3.62 B
	Gross Profit	1.88 B
	EBITDA	916.7 M
	Net Income	541.5 M
	Cash And Equivalents	2.37 B
	Cash Per Share	6.14 X
	Total Debt	2.59 B
	Debt To Equity	1.17 %
	Current Ratio	3.77 X
	Book Value Per Share	5.37 X
	Cash Flow From Operations	748.5 M
	Short Ratio	4.32 X
	Earnings Per Share	1.29 X
	Price To Earnings To Growth	2.53 X
	Target Price	151.05
	Number Of Employees	9.5 K
	Beta	1.21
	Market Capitalization	52.48 B
	Total Asset	6.26 B
	Retained Earnings	1.02 B
	Working Capital	2.87 B
	Current Asset	231.3 M
	Current Liabilities	66.9 M
	Net Asset	6.26 B

About DexCom Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DexCom Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DexCom using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DexCom Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with DexCom

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DexCom position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will appreciate offsetting losses from the drop in the long position's value.

Moving together with DexCom Stock

0.69

EHAB

Enhabit Financial Report 14th of May 2024

Pair Corr

Moving against DexCom Stock

0.79	POAI	Predictive Oncology	Pair Corr
0.78	MMSI	Merit Medical Systems Financial Report 24th of April 2024	Pair Corr
0.74	ACHC	Acadia Healthcare Financial Report 24th of April 2024	Pair Corr
0.73	LUCY	Innovative Eyewear	Pair Corr
0.7	FIGS	Figs Inc Financial Report 2nd of May 2024	Pair Corr

The ability to find closely correlated positions to DexCom could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DexCom when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DexCom - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DexCom Inc to buy it.

The correlation of DexCom is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DexCom moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DexCom Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for DexCom can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out DexCom Piotroski F Score and DexCom Altman Z Score analysis.

Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Commodity Directory Find actively traded commodities issued by global exchanges
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is DexCom's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.81

Earnings Share

1.29

Revenue Per Share

9.384

Quarterly Revenue Growth

0.269

Return On Assets

0.0641

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dexcom Inc Stock Gross Profit

DexCom Inc Company Gross Profit Analysis

Gross Profit

Revenue

-

Cost of Revenue

Current DexCom Gross Profit

DexCom Gross Profit Driver Correlations

DexCom Gross Profit Peer Comparison

DexCom ESG Sustainability

DexCom Fundamentals

About DexCom Fundamental Analysis

Pair Trading with DexCom

Moving together with DexCom Stock

Moving against DexCom Stock

Complementary Tools for DexCom Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY